Cargando…

Impact of the 2018 ASCO/CAP guidelines on HER2 fluorescence in situ hybridization interpretation in invasive breast cancers with immunohistochemically equivocal results

The American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) recently issued updated guidelines on human epidermal growth factor receptor 2 (HER2) testing by fluorescence in situ hybridization (FISH) in invasive breast cancers. In this study, we aimed to investigate the im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Bo, Ding, Wei, Sun, Ke, Wang, Xiaoling, Xu, Liming, Teng, Xiaodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854277/ https://www.ncbi.nlm.nih.gov/pubmed/31723206 http://dx.doi.org/10.1038/s41598-019-53003-w

Ejemplares similares

Indian Data on HER2 Fluorescence In Situ Hybridization in Invasive Breast Cancer with Immunohistochemically Equivocal Results As Per 2018 ASCO/CAP Guidelines
por: Nagarjun, B. R., et al.
Publicado: (2022)

Characteristics of HER2-negative breast cancers with FISH-equivocal status according to 2018 ASCO/CAP guideline
por: Kong, Hui, et al.
Publicado: (2022)

Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy
por: Crespo, James, et al.
Publicado: (2020)

Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/CAP ISH group 4 breast cancer
por: Gupta, Swati, et al.
Publicado: (2019)

Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines
por: Press, Michael F., et al.
Publicado: (2018)

Outcome of HER2 Testing by FISH applying ASCO/CAP 2007 and 2013 guideline in IHC equivocal group of breast cancer: Experience at tertiary cancer care centre
por: Panigrahi, Manoj Kumar, et al.
Publicado: (2017)

Impact of Modified 2013 ASCO/CAP Guidelines on HER2 Testing in Breast Cancer. One Year Experience
por: Varga, Zsuzsanna, et al.
Publicado: (2015)

The concordance between IHC and ISH for HER-2 testing in breast cancer in Nakhon Pathom Hospital, Thailand, based on the ASCO/CAP 2018 guidelines: a retrospective study
por: Thambamroong, Tawasapon
Publicado: (2022)

ASCO 2018: highlights in HER2-positive metastatic breast cancer
por: Bartsch, Rupert, et al.
Publicado: (2018)

Comparative Study between Quantitative Digital Image Analysis and Fluorescence In Situ Hybridization of Breast Cancer Equivocal HER2 2+ Cases
por: Ayad, E., et al.
Publicado: (2014)

Comparison of the FDA and ASCO/CAP Criteria for HER2 Immunohistochemistry in Upper Urinary Tract Urothelial Carcinoma
por: Kim, Gilhyang, et al.
Publicado: (2016)

ASCO Congress 2018: melanoma treatment
por: Richtig, Erika
Publicado: (2018)

Identification of challenges and a framework for implementation of the AMP/ASCO/CAP classification guidelines for reporting somatic variants
por: Parikh, Bijal A., et al.
Publicado: (2020)

ASCO 2018 highlights: metastatic breast cancer
por: Rinnerthaler, Gabriel, et al.
Publicado: (2018)

HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical Trials
por: Press, Michael F., et al.
Publicado: (2016)

ASCO Resource-Stratified Guidelines: Methods and Opportunities
por: Al-Sukhun, Sana, et al.
Publicado: (2018)

Robust and accurate digital measurement for HER2 amplification in HER2 equivocal breast cancer diagnosis
por: Wang, Yuefeng, et al.
Publicado: (2017)

ASCO 2018: highlights of urothelial cancer and prostate cancer
por: Pichler, Renate, et al.
Publicado: (2018)

ASCO 2018 NSCLC highlights—combination therapy is key
por: Gamerith, Gabriele, et al.
Publicado: (2018)

Usefulness analysis of the 2018 ASCO/IDSA guideline for outpatient management of fever and neutropenia in adults treated for malignancy
por: Hwang, Soyoon, et al.
Publicado: (2021)

Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification
por: Agersborg, Sally, et al.
Publicado: (2018)

Importance of formalin fixing conditions for HER2 testing in gastric cancer: immunohistochemical staining and fluorescence in situ hybridization
por: Yamashita-Kashima, Yoriko, et al.
Publicado: (2014)

Erratum to: Importance of formalin fixing conditions for HER2 testing in gastric cancer: immunohistochemical staining and fluorescence in situ hybridization
por: Yamashita-Kashima, Yoriko, et al.
Publicado: (2014)

The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment
por: Marchiò, Caterina, et al.
Publicado: (2018)

Early Detection for Colorectal Cancer: ASCO Resource-Stratified Guideline
por: Lopes, Gilberto, et al.
Publicado: (2019)

Insulinoma with equivocal imaging
por: Belabed, Wafa, et al.
Publicado: (2023)

Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer
por: Kwak, Yoonjin, et al.
Publicado: (2017)

Evaluation of ERBB2 mRNA Expression in HER2-Equivocal (2+) Immunohistochemistry Cases
por: Carretero-Barrio, Irene, et al.
Publicado: (2023)

Palliative Care in the Global Setting: ASCO Resource-Stratified Practice Guideline
por: Osman, Hibah, et al.
Publicado: (2018)

Secondary Prevention of Cervical Cancer: ASCO Resource–Stratified Guideline Update
por: Shastri, Surendra S., et al.
Publicado: (2022)

Evaluation of Immunohistochemistry-Equivocal (2+) HER2 Gene Status in Invasive Breast Cancer by Silver DNA in Situ Hybridization (SISH) and its Association with Clinicopathological Variables
por: A. Musa, Zaidoon, et al.
Publicado: (2017)

Update on hepatocellular carcinoma from the 2018 Gastrointestinal Cancer Symposium (ASCO GI)
por: de Jesus, Victor Hugo Fonseca, et al.
Publicado: (2018)

Observations in Support of Equivocal Generation
Publicado: (1811)

ASCO update on lymphoma
por: Fridrik, Michael A.
Publicado: (2017)

From ASCO 2022
por: Romero, Diana
Publicado: (2022)

Highlights of ASCO 2023
por: Neugut, Alfred I, et al.
Publicado: (2023)

Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline
por: Jeronimo, Jose, et al.
Publicado: (2016)

Treatment of Patients With Early-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline
por: Costas-Chavarri, Ainhoa, et al.
Publicado: (2019)

Treatment of Patients With Late-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline
por: Chiorean, E. Gabriela, et al.
Publicado: (2020)

Neues aus der Urologie von GU-ASCO, ASCO und EAU
por: Schnabel, Marco J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_viqa41sbotsc73j9igmuhj812o